Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1998 1
2008 1
2009 1
2010 1
2011 1
2012 2
2013 2
2014 2
2015 5
2016 5
2017 2
2018 6
2019 7
2021 2
2022 5
2023 7
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

45 results

Results by year

Filters applied: . Clear all
The following term was not found in PubMed: Sharpyonok
Page 1
Alpelisib for PIK3CA-Mutated, Hormone Receptor-Positive Advanced Breast Cancer.
André F, Ciruelos E, Rubovszky G, Campone M, Loibl S, Rugo HS, Iwata H, Conte P, Mayer IA, Kaufman B, Yamashita T, Lu YS, Inoue K, Takahashi M, Pápai Z, Longin AS, Mills D, Wilke C, Hirawat S, Juric D; SOLAR-1 Study Group. André F, et al. N Engl J Med. 2019 May 16;380(20):1929-1940. doi: 10.1056/NEJMoa1813904. N Engl J Med. 2019. PMID: 31091374 Clinical Trial.
Genetic Causes of Rare Pediatric Ovarian Tumors.
Plevová P, Geržová H. Plevová P, et al. Klin Onkol. 2019 Summer;32(Supplementum2):79-91. doi: 10.14735/amko2019S79. Klin Onkol. 2019. PMID: 31409083 English.
., (Institute of Pathology, University Hospital Ostrava) for rewarding advice, Mrs. Jana Němcova (Department of Medical Genetics, University Hospital Ostrava), Bc. Ludmila Stuchla and Mrs. Lenka Zivčakova (Medical Library, University Hospital Ostra …
., (Institute of Pathology, University Hospital Ostrava) for rewarding advice, Mrs. Jana Němcova (Department of Medical Gene …
Contribution of Molecular Structure to Self-Assembling and Biological Properties of Bifunctional Lipid-Like 4-(N-Alkylpyridinium)-1,4-Dihydropyridines.
Rucins M, Dimitrijevs P, Pajuste K, Petrichenko O, Jackevica L, Gulbe A, Kibilda S, Smits K, Plotniece M, Tirzite D, Pajuste K, Sobolev A, Liepins J, Domracheva I, Plotniece A. Rucins M, et al. Pharmaceutics. 2019 Mar 12;11(3):115. doi: 10.3390/pharmaceutics11030115. Pharmaceutics. 2019. PMID: 30871041 Free PMC article.
We have revealed that the mean diameter of freshly prepared nanoparticles varied from 58 to 513 nm, depending upon the 4-(N-alkylpyridinium)-1,4-DHP structure. Additionally, we have confirmed that only nanoparticles formed by 4-(N-dodecylpyridinium)-1,4-DHP derivati …
We have revealed that the mean diameter of freshly prepared nanoparticles varied from 58 to 513 nm, depending upon the 4-(N-alkylpyri …
Melanoma and immunotherapy bridge 2015 : Naples, Italy. 1-5 December 2015.
Nanda VGY, Peng W, Hwu P, Davies MA, Ciliberto G, Fattore L, Malpicci D, Aurisicchio L, Ascierto PA, Croce CM, Mancini R, Spranger S, Gajewski TF, Wang Y, Ferrone S, Vanpouille-Box C, Wennerberg E, Pilones KA, Formenti SC, Demaria S, Tang H, Wang Y, Fu YX, Dummer R, Puzanov I, Tarhini A, Chauvin JM, Pagliano O, Fourcade J, Sun Z, Wang H, Sanders C, Kirkwood JM, Chen THT, Maurer M, Korman AJ, Zarour HM, Stroncek DF, Huber V, Rivoltini L, Thurin M, Rau T, Lugli A, Pagès F, Camarero J, Sancho A, Jommi C, de Coaña YP, Wolodarski M, Yoshimoto Y, Gentilcore G, Poschke I, Masucci GV, Hansson J, Kiessling R, Scognamiglio G, Sabbatino F, Marino FZ, Anniciello AM, Cantile M, Cerrone M, Scala S, D’alterio C, Ianaro A, Cirin G, Liguori G, Bott G, Chapman PB, Robert C, Larkin J, Haanen JB, Ribas A, Hogg D, Hamid O, Testori A, Lorigan P, Sosman JA, Flaherty KT, Yue H, Coleman S, Caro I, Hauschild A, McArthur GA, Sznol M, Callahan MK, Kluger H, Postow MA, Gordan R, Segal NH, Rizvi NA, Lesokhin A, Atkins MB, Burke MM, Ralabate A, Rivera A, Kronenberg SA, Agunwamba B, Ruisi M, Horak C, Jiang J, Wolchok J, Ascierto PA, Liszkay G, Maio M, Mandalà M, Demidov L, Stoyakovskiy D, Thomas L, de la Cruz-Me… See abstract for full author list ➔ Nanda VGY, et al. J Transl Med. 2016 Jul 25;14(1):65. doi: 10.1186/s12967-016-0791-2. J Transl Med. 2016. PMID: 27461275 Free PMC article.
Battarra IMMUNOTHERAPY BRIDGE KEYNOTE SPEAKER PRESENTATIONS Immunotherapy beyond melanoma K19 Predictor of response to radiation and immunotherapy Silvia Formenti K20 Response and resistance to PD-1 pathway blockade: clues from the tumor microenvironment Maria Libera Ascierto, Tr …
Battarra IMMUNOTHERAPY BRIDGE KEYNOTE SPEAKER PRESENTATIONS Immunotherapy beyond melanoma K19 Predictor of response to radiation and immunot …
A newly discovered biodiversity hotspot of many-plumed moths in the Mount Cameroon area: first report on species diversity, with description of nine new species (Lepidoptera, Alucitidae).
Ustjuzhanin P, Kovtunovich V, Sáfián S, Maicher V, Tropek R. Ustjuzhanin P, et al. Zookeys. 2018 Jul 30;(777):119-139. doi: 10.3897/zookeys.777.24729. eCollection 2018. Zookeys. 2018. PMID: 30100792 Free PMC article.
Nine species: Alucitalongipenis Ustjuzhanin & Kovtunovich, sp. n., A.lidiya Ustjuzhanin & Kovtunovich, sp. n., A.ludmila Ustjuzhanin & Kovtunovich, sp. n., A.escobari Ustjuzhanin & Kovtunovich, sp. n., A.mischenini Ustjuzhanin &a …
Nine species: Alucitalongipenis Ustjuzhanin & Kovtunovich, sp. n., A.lidiya Ustjuzhanin & Kovtunovich, sp. n., A.lu …
Can lifelong endurance exercise improve ageing through beneficial effects on circadian timing function, muscular performance and health status in men? Protocol for a comparative cross-sectional study.
Berisha G, Sedliak M, Zeman M, Hamar D, Cvečka J, Tirpáková V, Vajda M, Oreská Ľ, Černáčková A, Čupka M, Šarabon N, Protasi F, Zampieri S, Kern H, Lofler S, Musaro A, Stebelová K, Okuliarová M. Berisha G, et al. Eur J Transl Myol. 2023 Dec 5;33(4):10.4081/ejtm.2023. 12012. doi: 10.4081/ejtm.2023.12012. Eur J Transl Myol. 2023. PMID: 38058287 Free PMC article.
The study protocol has a comparative cross-sectional design, including groups of senior (65 to 75 years old, n=16) and young (20-30 years old, n=16) endurance runners and triathletes. ...
The study protocol has a comparative cross-sectional design, including groups of senior (65 to 75 years old, n=16) and young (20-30 y …
Etrolizumab versus adalimumab or placebo as induction therapy for moderately to severely active ulcerative colitis (HIBISCUS): two phase 3 randomised, controlled trials.
Rubin DT, Dotan I, DuVall A, Bouhnik Y, Radford-Smith G, Higgins PDR, Mishkin DS, Arrisi P, Scalori A, Oh YS, Tole S, Chai A, Chamberlain-James K, Lacey S, McBride J, Panés J; HIBISCUS Study Group. Rubin DT, et al. Lancet Gastroenterol Hepatol. 2022 Jan;7(1):17-27. doi: 10.1016/S2468-1253(21)00338-1. Epub 2021 Nov 17. Lancet Gastroenterol Hepatol. 2022. PMID: 34798036 Clinical Trial.
Each study enrolled and randomly assigned 358 patients (HIBISCUS I etrolizumab n=144, adalimumab n=142, placebo n=72; HIBISCUS II etrolizumab n=143; adalimumab n=143; placebo n=72). ...
Each study enrolled and randomly assigned 358 patients (HIBISCUS I etrolizumab n=144, adalimumab n=142, placebo n=72; H …
Effects of medications for opioid use disorder (MOUD) on fetal brain and cranial measurements.
Chao CR, Perez Yordan J, Roberts M, Ma X, Holbrook B, Rayburn W, Bakhireva LN. Chao CR, et al. Neurotoxicol Teratol. 2023 May-Jun;97:107177. doi: 10.1016/j.ntt.2023.107177. Epub 2023 Apr 19. Neurotoxicol Teratol. 2023. PMID: 37084853 Free PMC article.
METHODS: This study was a secondary analysis of a prospective cohort study among participants (n = 196) assigned into three groups (MOUD [n = 94], MOUD+Alcohol [n = 47], and unexposed controls [n = 55]). ...
METHODS: This study was a secondary analysis of a prospective cohort study among participants (n = 196) assigned into three groups (M …
45 results